Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the sale of its Quantum Sniffer™ QS-B220 and QS-H150 explosives trace detectors to a new customer in the Middle East.
"The Quantum Sniffer's reputation for fast reliable performance even in challenging environmental conditions continues to help Implant Sciences gain new customers in the security-conscious Middle East," stated Implant Sciences' Vice President of Sales and Marketing, Darryl Jones. "Worldwide, Implant Sciences' trace detection systems are deployed for a wide variety of security applications in 39 different countries."
"Since we launched our first trace detection system nearly ten years ago, it has been apparent that we had something special. With industry leading capabilities that include a non-radioactive ion source, non-contact sampling, automatic internal calibration, and push-button maintenance and diagnostics, Implant Sciences is the next generation of trace detection," stated Implant Sciences' President and CEO, Glenn D. Bolduc.
Source: Implant Sciences Corp.
Date: Feb 21, 2013